FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals’ supplemental application for metoclopramide, updating the regulatory status of this generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Diabetic Gastroparesis
• Gastroesophageal Reflux Disease
• Gastroparesis
• Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Metoclopramide (metoclopramide)

Snippet

SUPPL AP for METOCLOPRAMIDE (METOCLOPRAMIDE)